STRS Ohio’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $686K | Sell |
84,600
-6,900
| -8% | -$50.5K | ﹤0.01% | 972 |
|
|
2026
Q1 | $585K | Sell |
91,500
-7,900
| -8% | -$50.9K | ﹤0.01% | 982 |
|
|
2025
Q4 | $591K | Sell |
99,400
-25,500
| -20% | -$135K | ﹤0.01% | 945 |
|
|
2025
Q3 | $663K | Sell |
124,900
-22,400
| -15% | -$95K | ﹤0.01% | 869 |
|
|
2025
Q2 | $505K | Buy |
147,300
+5,400
| +4% | +$17.2K | ﹤0.01% | 1288 |
|
|
2025
Q1 | $420K | Sell |
141,900
-43,500
| -23% | -$136K | ﹤0.01% | 1279 |
|
|
2024
Q4 | $565K | Sell |
185,400
-16,000
| -8% | -$46.6K | ﹤0.01% | 1118 |
|
|
2024
Q3 | $514K | Buy |
201,400
+42,100
| +26% | +$127K | ﹤0.01% | 1248 |
|
|
2024
Q2 | $519K | Buy |
+159,300
| New | +$699K | ﹤0.01% | 1218 |
|
|
2022
Q2 | – | Sell |
-237,000
| Closed | -$682K | – | 2219 |
|
|
2022
Q1 | $682K | Hold |
237,000
| – | – | ﹤0.01% | 1296 |
|
|
2021
Q4 | $720K | Buy |
237,000
+130,400
| +122% | +$566K | ﹤0.01% | 1339 |
|
|
2021
Q3 | $747K | Buy |
106,600
+28,100
| +36% | +$210K | ﹤0.01% | 1317 |
|
|
2021
Q2 | $720K | Buy |
78,500
+15,400
| +24% | +$156K | ﹤0.01% | 1417 |
|
|
2021
Q1 | $613K | Hold |
63,100
| – | – | ﹤0.01% | 1485 |
|
|
2020
Q4 | $647K | Buy |
63,100
+33,700
| +115% | +$341K | ﹤0.01% | 1333 |
|
|
2020
Q3 | $296K | Hold |
29,400
| – | – | ﹤0.01% | 1571 |
|
|
2020
Q2 | $306K | Buy |
29,400
+5,800
| +25% | +$60K | ﹤0.01% | 1526 |
|
|
2020
Q1 | $199K | Hold |
23,600
| – | – | ﹤0.01% | 1545 |
|
|
2019
Q4 | $206K | Buy |
23,600
+4,100
| +21% | +$33.9K | ﹤0.01% | 1670 |
|
|
2019
Q3 | $209K | Buy |
+19,500
| New | +$211K | ﹤0.01% | 1631 |
|
|
2018
Q2 | – | Sell |
-16,700
| Closed | -$1.14M | – | 2162 |
|
|
2018
Q1 | $1.14M | Buy |
16,700
+2,500
| +18% | +$187K | 0.01% | 807 |
|
|
2017
Q4 | $1.4M | Buy |
14,200
+11,500
| +426% | +$1.29M | 0.01% | 709 |
|
|
2017
Q3 | $323K | Buy |
2,700
+1,300
| +93% | +$121K | ﹤0.01% | 1463 |
|
|
2017
Q2 | $122K | Buy |
+1,400
| New | +$78.3K | ﹤0.01% | 1592 |
|
|
2015
Q4 | – | Sell |
-559
| Closed | -$42K | – | 1943 |
|
|
2015
Q3 | $42K | Buy |
+559
| New | +$52.9K | ﹤0.01% | 1774 |
|
|
2015
Q2 | – | Sell |
-11,100
| Closed | -$2.62M | – | 1917 |
|
|
2015
Q1 | $2.62M | Buy |
11,100
+200
| +2% | +$42.8K | 0.01% | 594 |
|
|
2014
Q4 | $2.06M | Buy |
10,900
+700
| +7% | +$155K | 0.01% | 614 |
|
|
2014
Q3 | $2.43M | Sell |
10,200
-7,800
| -43% | -$1.6M | 0.01% | 610 |
|
|
2014
Q2 | $1.19M | Buy |
18,000
+8,500
| +89% | +$604K | 0.01% | 700 |
|
|
2014
Q1 | $989K | Buy |
9,500
+7,200
| +313% | +$846K | ﹤0.01% | 745 |
|
|
2013
Q4 | $238K | Buy |
+2,300
| New | +$135K | ﹤0.01% | 1404 |
|
Other funds holding PBYI
ACA
STRS Ohio's PBYI Position: Q2 2026 in Review
STRS Ohio reduced its Puma Biotechnology (PBYI) stake by 7.5% in Q2 2026, selling an estimated $50.5K and leaving 84,600 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #972.
STRS Ohio first reported a position in PBYI in Q4 2013 and has held it in 31 quarters since. The position peaked at $2.62M in Q1 2015. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.
- STRS Ohio held 84,600 shares of Puma Biotechnology worth $686K as of Q2 2026.
- STRS Ohio sold 6,900 Puma Biotechnology shares in Q2 2026, an estimated $50.5K.
- Puma Biotechnology made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #972 holding.
- STRS Ohio first reported a position in Puma Biotechnology in Q4 2013 and has held it in 31 quarters since.
- STRS Ohio's Puma Biotechnology position peaked at $2.62M in Q1 2015.
- 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.
Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.